Adicet Bio

Adicet Bio, Inc. (Nasdaq: ACET) is a clinical-stage biotechnology company with offices in Redwood City, California and Boston, Massachusetts, discovering and developing allogeneic "off-the-shelf" gamma delta T cell therapies engineered with chimeric antigen receptors (CARs) for autoimmune disease and cancer. Its lead candidate, prulacabtagene leucel (prula-cel), is an anti-CD20 gamma delta CAR T cell therapy in development for B cell-mediated autoimmune diseases, alongside ADI-212 for metastatic castration-resistant prostate cancer. Adicet publishes a corporate website covering its science platform, clinical pipeline, leadership and careers, plus a vendor-hosted investor relations portal. It operates no public developer program, API, SDK, or machine-readable interface of any kind; this profile records that absence rather than an API surface.

Adicet Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Cell Therapy, and Immunotherapy.

Adicet Bio’s developer surface includes support and 7 more developer resources.

10.7/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-07 · rubric v0.20.0
0 APIs
CompanyBiotechnologyLife SciencesCell TherapyImmunotherapyOncologyAutoimmuneClinical TrialsPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-07 · rubric v0.20.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/adicet-bio: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Adicet Bio Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: adicet-bio
name: Adicet Bio
description: 'Adicet Bio, Inc. (Nasdaq: ACET) is a clinical-stage biotechnology company with offices in Redwood City, California
  and Boston, Massachusetts, discovering and developing allogeneic "off-the-shelf" gamma delta T cell therapies engineered
  with chimeric antigen receptors (CARs) for autoimmune disease and cancer. Its lead candidate, prulacabtagene leucel (prula-cel),
  is an anti-CD20 gamma delta CAR T cell therapy in development for B cell-mediated autoimmune diseases, alongside ADI-212
  for metastatic castration-resistant prostate cancer. Adicet publishes a corporate website covering its science platform,
  clinical pipeline, leadership and careers, plus a vendor-hosted investor relations portal. It operates no public developer
  program, API, SDK, or machine-readable interface of any kind; this profile records that absence rather than an API surface.'
image: https://www.adicetbio.com/themes/default/images/logo.svg
url: https://raw.githubusercontent.com/api-evangelist/adicet-bio/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-07'
modified: '2026-09-07'
tags:
- Company
- Biotechnology
- Life Sciences
- Cell Therapy
- Immunotherapy
- Oncology
- Autoimmune
- Clinical Trials
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: LLMsTxt
  url: llms/adicet-bio-llms.txt
- type: DomainSecurity
  url: security/adicet-bio-domain-security.yml
- type: Website
  url: https://www.adicetbio.com/
- type: About
  url: https://www.adicetbio.com/about/
- type: Support
  url: https://www.adicetbio.com/contact/
- type: TermsOfService
  url: https://www.adicetbio.com/terms-of-use/
- type: PrivacyPolicy
  url: https://www.adicetbio.com/privacy/
- type: Careers
  url: https://www.adicetbio.com/careers/openings/
x-enrichment:
  date: '2026-09-07'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Adicet Bio is a clinical-stage cell-therapy biotech — its products are investigational gamma delta CAR T cell therapies,
    not software — and its entire public surface is a nine-page corporate marketing site plus a vendor-hosted investor relations
    portal; every OpenAPI, Swagger, GraphQL, MCP, agent-card and /.well-known/ path probed on adicetbio.com, www.adicetbio.com
    and investor.adicetbio.com returned 404, 301 or 403, and the site contains no developer, API, docs or integrations link
    anywhere in its navigation.
  evidence:
  - url: https://www.adicetbio.com/openapi.json
    status: 404
  - url: https://www.adicetbio.com/.well-known/agent-card.json
    status: 404
  - url: https://www.adicetbio.com/llms.txt
    status: 404
  - url: https://www.adicetbio.com/graphql
    status: 404
  - url: https://www.adicetbio.com/
    status: 200
  checked: '2026-09-07'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/adicet-bio"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/adicet-bio/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/adicet-bio/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.